Moguillansky Natalia, DeSear Kathryn, Dousa Khalid M
Department of Medicine, Division of Pulmonary Critical Care and Sleep Medicine, University of Florida Health, Gainesville, USA.
Department of Pharmacy, University of Florida Shands Hospital, Gainesville, USA.
Cureus. 2023 Jun 26;15(6):e40993. doi: 10.7759/cureus.40993. eCollection 2023 Jun.
Nontuberculous mycobacteria (NTM) infections are difficult to treat conditions, specially () lung disease. The most recent ATS/ERS/ESCMID/IDSA clinical practice guidelines (2020) recommend regimens of multiple intravenous (IV) and oral antibiotics. Recent in vitro studies on show that the combination of two beta-lactam antibiotics, as well as select beta-lactamase inhibitors, provides significant synergy in its treatment. We present the first in vivo case of the successful treatment of with imipenem and amoxicillin in addition to macrolides, clofazimine, and inhaled liposomal amikacin.
非结核分枝杆菌(NTM)感染是难以治疗的病症,尤其是肺部疾病。最新的美国胸科学会(ATS)/欧洲呼吸学会(ERS)/欧洲临床微生物与感染性疾病学会(ESCMID)/美国感染病学会(IDSA)临床实践指南(2020年)推荐了多种静脉注射(IV)和口服抗生素的治疗方案。最近关于[具体内容缺失]的体外研究表明,两种β-内酰胺类抗生素以及某些β-内酰胺酶抑制剂的联合使用在其治疗中具有显著的协同作用。我们报告了首例使用亚胺培南、阿莫西林联合大环内酯类、氯法齐明和吸入性脂质体阿米卡星成功治疗[具体病症缺失]的体内病例。